Literature DB >> 10229152

Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.

A Obana1, Y Gohto, K Kaneda, S Nakajima, T Takemura, T Miki.   

Abstract

BACKGROUND AND
OBJECTIVE: To determine the optimal treatment parameters for selective occlusion of choroidal neovascularization (CNV) by photodynamic therapy (PDT) by using the photosensitizer ATX-S10 and a diode laser (wavelength = 670 nm).
MATERIALS AND METHODS: Experimental CNV was induced in rat fundi by argon laser photocoagulation. The distribution of ATX-S10 in the chorioretina was analyzed by fluorescence microscopy, and the optimal treatment parameters for selective occlusion of CNV were investigated by changing the dosage and timing of laser irradiation. CNV closure and resulting damage of the surrounding tissue were documented by fluorescein angiography and light and electron microscopies.
RESULTS: Fluorescence of ATX-S10 was observed to be localized in the vascular lumen of the retina and choroid within 5 min after dye injection and increased in intensity in CNV up to 2-6 h and decreased rapidly in normal tissue. Laser irradiation with radiant exposures of 7.4 J/cm2 applied immediately after dye injection or with 22.0 J/cm2 at 2-4 h later effectively occluded the induced CNV without causing significant damage to normal retinal capillaries and large choroidal vessels.
CONCLUSIONS: PDT using ATX-S10 can selectively occlude CNV. ATX-S10 is a potentially useful photosensitizer for the treatment of CNV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229152     DOI: 10.1002/(sici)1096-9101(1999)24:3<209::aid-lsm6>3.0.co;2-l

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  4 in total

Review 1.  Current and future treatment options for nonexudative and exudative age-related macular degeneration.

Authors:  Grant M Comer; Thomas A Ciulla; Mark H Criswell; Michael Tolentino
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

2.  Photodynamic therapy with ATX-S10.Na(II) inhibits synovial sarcoma cell growth.

Authors:  Ken Takeda; Toshiyuki Kunisada; Shinichi Miyazawa; Yoshinori Nakae; Toshifumi Ozaki
Journal:  Clin Orthop Relat Res       Date:  2008-05-09       Impact factor: 4.176

3.  Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation.

Authors:  Masamitsu Tanaka; Pawel Mroz; Tianhong Dai; Liyi Huang; Yuji Morimoto; Manabu Kinoshita; Yasuo Yoshihara; Koichi Nemoto; Nariyoshi Shinomiya; Suhji Seki; Michael R Hamblin
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

4.  Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.

Authors:  M Mori; I Sakata; T Hirano; A Obana; S Nakajima; M Hikida; T Kumagai
Journal:  Jpn J Cancer Res       Date:  2000-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.